Features
A glimpse into future cholesterol control: A time without daily pills perhaps?
Specialist Consultant Paediatrician and Honorary Senior Fellow, Postgraduate Institute of Medicine, University of Colombo, Sri Lanka. Joint Editor, Sri Lanka Journal of Child Health
Section Editor, Ceylon Medical Journal
For millions of people worldwide, the daily ritual of taking a statin or other drugs to manage cholesterol levels is a fact of life. These powerful medications have dramatically reduced the risk of heart attacks and strokes, thereby transforming cardiovascular healthcare. However, the hassle of having to take these medicines every day is a cumbersome infringement on life itself.
Now, imagine a future where the burden of daily pills for this purpose could be replaced by a single, or at most, a few injections per year. This is NOT science fiction; it is the audacious goal of a new frontier in medicine, with revolutionary drugs currently undergoing rigorous clinical trials. These cutting-edge therapies are designed to act directly in the liver, targeting the very genetic instructions or enzymes responsible for producing “bad” cholesterol, potentially offering a more profound and long-lasting solution than ever before.
This appears to be the dawn of a new era with medicines that employ gene-silencing and enzyme-neutralisation techniques. The excitement surrounding these new treatments stems from their innovative approaches. Unlike traditional statins, which work by blocking an enzyme involved in cholesterol production, these newer drugs go further upstream, interfering with the body’s internal machinery that regulates cholesterol at a more fundamental level.
Two primary classes of these emerging therapies are making waves at present:
1. PCSK9 Inhibitors: A Deeper Dive
There are a few currently approved drugs that inhibit PCSK9 gene. But they require injections every two to four weeks. These antibody-based drugs work by binding to and neutralising a protein called PCSK9 (Proprotein Convertase Subtilisin/Kexin type 9), which acts like a “destroyer” of LDL receptors on the surface of liver cells. These LDL receptors are crucial for grabbing “bad” LDL cholesterol from the bloodstream and bringing it into the liver for processing and removal. By blocking PCSK9, these inhibitors allow more LDL receptors to remain active on liver cells, significantly boosting the liver’s capacity to clear LDL cholesterol from the blood.
The truly groundbreaking development now is a group of medicines that aim to permanently or durably turn off the PCSK9 gene itself. Instead of needing regular injections to block the protein, a single treatment could, in theory, silence the gene that produces it, offering a lifelong reduction in cholesterol.
One such investigational drug is VERVE-102, developed by Verve Therapeutics. This is designed to be a single-course treatment. It uses a modified technology to make a precise “edit” to the PCSK9 gene in liver cells, effectively switching it off. Early data from clinical trials have shown promising results, with participants achieving significant reductions in LDL cholesterol. For instance, in one cohort, a mean LDL-C reduction of 53% was observed, with a maximum reduction of 69% in a single participant. The long-term durability of this effect is what truly excites researchers, with the hope that such a treatment could eliminate the need for ongoing regular daily medication.
2. ANGPTL3 Inhibitors: A Different Angle
Another fascinating target is the angiopoietin-like protein 3 (ANGPTL3). This protein, primarily secreted by the liver, acts as an inhibitor of two key enzymes: lipoprotein lipase (LPL) and endothelial lipase (EL). These lipases are essential for breaking down triglycerides and processing lipoproteins, including LDL cholesterol. When ANGPTL3 is inhibited, LPL and EL become more active, leading to a reduction in triglycerides, LDL cholesterol, and even HDL cholesterol.
A monoclonal antibody drug called Evinacumab (Evkeeza) is an example of an ANGPTL3 inhibitor already approved for a rare genetic condition called homozygous familial hypercholesterolemia (HoFH), requiring monthly intravenous infusions. However, research is ongoing into one-time or infrequent dose ANGPTL3-targeting therapies, potentially using gene-silencing technologies similar to those for PCSK9. Some of these medicines have shown significant reductions in ANGPTL3 and various atherogenic lipoproteins in preclinical and early human studies with a single dose.
It is absolutely vital to reiterate that these revolutionary treatments are still in various stages of clinical trials. These trials are meticulously structured processes designed to ensure that any new medication is both safe and effective before it can be made available to the public. Before human trials begin, new treatments are extensively tested in laboratories and on animals to assess their basic safety and potential efficacy. Then come Phase 1 Trials, which are the first human tests, typically involving a small group of healthy volunteers (around 20-100 people) or patients with the condition. The primary goal is to assess the drug’s safety, determine a safe dosage range, and identify common side effects. For gene-editing therapies, these initial phases are particularly critical to monitor for any unintended genetic changes or off-target effects.
Then, Phase 2 Trials follow. If a drug proves to be safe in Phase 1, it moves to Phase 2, involving a larger group of patients (typically 100-300) who have the specific condition the drug aims to treat. The focus here is to evaluate the drug’s effectiveness and continue monitoring for side effects. Researchers fine-tune dosages and study how the drug impacts the disease.
Then it graduates to Phase 3 Trial. This is the most extensive and crucial phase, involving hundreds to thousands of patients over several years, often across multiple international sites. In Phase 3, the new treatment is compared against existing standard-of-care treatments or a placebo (an inactive substance) to confirm its efficacy and safety on a larger scale. This phase generates the robust data needed for regulatory approval.
The final stage are Phase 4 Trials. Even after a drug receives approval and enters the market, Phase 4 trials continue. These are post-marketing surveillance studies that monitor the drug’s long-term effects, identify any rare side effects that may not have appeared in smaller trials, and explore new uses or populations.
For gene-editing therapies like VERVE-102, the journey through these phases is even more closely scrutinised due to the permanent nature of the genetic changes they induce. While early results are exciting, only successful completion of large-scale Phase 3 trials and ongoing Phase 4 monitoring will fully confirm their long-term safety and effectiveness. Companies like Verve Therapeutics are planning to move into Phase 2 trials for VERVE-102 in the second half of 2025, a significant step forward.
Will all these new developments lead to an “Economic Earthquake” and a Shake-Up for the Pharmaceutical Industry? The potential advent of one-time or very infrequent cholesterol treatments carries enormous implications, not just for patients but also for the multi-billion-dollar pharmaceutical industry.
Statins have been one of the most successful drug classes in history, generating immense revenues for pharmaceutical companies over decades, the so-called Statin Empire.. They are widely prescribed, often for life, creating a consistent market. The prospect of a single-dose cure could, in the long run, significantly shrink this market.
Developing gene-editing therapies and complex biologic drugs like these new cholesterol treatments is incredibly expensive, requiring massive investments in research, development, and clinical trials. To recoup these costs and generate profit, these drugs are expected to command extremely high prices, at least initially. Existing PCSK9 inhibitors, for example, were initially priced around $14,000 per year, though costs have since decreased. A one-time gene-editing therapy could potentially run into hundreds of thousands of dollars per patient.
Healthcare systems and insurance providers will face a monumental challenge in determining how to pay for such expensive, high-impact treatments. While a one-time treatment might be cost-effective over a patient’s lifetime compared to decades of daily pills, the upfront cost can be a major barrier. This could lead to intense negotiations between pharmaceutical companies and payers, and potentially restricted access for patients.
Pharmaceutical companies that have historically relied on chronic, daily medications might need to undertake a pivotal change in their business strategies. The focus could shift from high-volume sales of inexpensive pills to lower-volume, high-value, transformative gene therapies. This requires different manufacturing capabilities, distribution networks, and marketing approaches and most importantly, are likely to be very expensive.
Beyond the economics, the high cost raises significant ethical questions about equitable access. Will these life-changing therapies only be available to those with comprehensive insurance or significant financial resources, creating a two-tiered system of care? This is a critical societal discussion that will undoubtedly unfold as these drugs get closer to the perennial drug market.
Epilogue
This author believes that our attitude to all these promulgations will need to be one of “Hope on the Horizon, Caution in the Present”. The research into one-time cholesterol-lowering injections is undeniably thrilling. The idea of a treatment that could potentially offer lifelong protection against cardiovascular disease with minimal ongoing effort is a medical dream. They would represent a paradigm shift in how we approach chronic diseases, moving from symptom management to root-cause intervention through genetic or enzymatic targeting.
However, it is paramount and absolutely vital for the public to understand that this future is not here, not as yet. These drugs are still experimental, undergoing rigorous scrutiny in clinical trials to ensure their safety and efficacy over the long term. While the early data is highly encouraging, the full picture of their benefits, potential risks, and accessibility will only become clear in the coming years.
For now, the message remains consistent. Work closely with your healthcare provider to manage your cholesterol, using established, approved therapies and healthy lifestyle choices. But keep an eye on the horizon: the landscape of cholesterol treatment is on the cusp of a truly revolutionary transformation.
This article was written with some
assistance from Artificial Intelligence.
Dr B. J. C. Perera
MBBS(Cey), DCH(Cey), DCH(Eng), MD(Paed), MRCP(UK), FRCP(Edin), FRCP(Lond), FRCPCH(UK), FSLCPaed, FCCP, Hony. FRCPCH(UK), Hony. FCGP(SL)
Features
The university bought AI, now it’s buying back the pencil
SERIES: THE GREAT DIGITAL RETHINK — PART IV OF V
Higher education spent 30 years going paperless. It digitised the lecture, the library, the exam hall and the staffroom. Then a student typed ‘write me an essay on Keynesian economics’ into a chatbot and handed it in. Now universities are doing something they have not done since the typewriter arrived: they are bringing back the pen.
The Most Digitised Place on Earth
If you wanted to find the institution most thoroughly transformed by digital technology, over the past three decades, the university is a strong candidate. The library card catalogue, once a tactile index of civilisation, is a database accessible from a phone in bed. Essays are submitted through portals, graded on screen, returned with tracked-change comments. Research is conducted on platforms, published in digital journals, cited by algorithms. Administrative life, timetabling, enrolment, fees, complaints, is almost entirely online. The university is, in the most literal sense, a paperless institution.
But the pen is coming back. And the reason is artificial intelligence, the very technology that was supposed to represent the final and irresistible triumph of digital over analogue in higher education.
Digital technology entered universities promising to make assessment smarter, faster and more flexible. It has instead produced a crisis of academic integrity so acute that the most sophisticated educational institutions in the world are responding by retreating to the oldest assessment technology available: a human being, a piece of paper, a pen, and a room with a clock on the wall.
Seven Thousand Caught. How Many Not?
In 2025, investigative reporting revealed that UK universities recorded nearly 7,000 confirmed cases of AI-assisted cheating in the 2023-24 academic year alone, roughly five cases per 1,000 students, five times the rate of the previous year. Experts quoted in the reporting were consistent in their view that confirmed cases represent a fraction of actual AI-assisted submissions. Nobody knows what the real number is. That, in itself, is the problem.
A student who prompts a language model to draft an essay on Keynesian economics, then edits the output to match their own voice and argumentation style, may produce something that no detection tool can reliably identify as machine-generated. The model writes fluently, cites credibly and argues coherently. The student submits with a clear conscience, having persuaded themselves that they were ‘using a tool’, in the same way they might use a calculator or a spell-checker.
Universities have responded with a spectrum of policies ranging from total prohibition of AI to the handwritten exam re-enters the story.
5,000 cases of AI cheating confirmed in a single year in UK universities. Experts say that’s the tip of the iceberg. The pen is suddenly looking very attractive again.
The Comeback of the Exam Hall
The move back is being driven not by a sudden rediscovery of pedagogical virtue but by the uncomfortable realisation that the alternatives, take-home essays, online submissions, project-based work submitted asynchronously, are now so vulnerable to AI assistance that they cannot reliably measure what the degree certificate claims to certify.
There is an additional irony, familiar to readers of this series, in the fact that AI-based exam has itself been in retreat since 2024, after mounting evidence of privacy violations, algorithmic bias and the fundamental absurdity of software that flags a student as a potential cheat for looking away from the screen to think. The technology brought in to protect digital assessment from human dishonesty has been replaced, in an increasing number of institutions, by a human invigilator. The wheel has turned.
The Open Laptop and Wandering Mind
The evidence is clear that open laptops in lectures serve, for a significant proportion of students, as gateways to everything except the lecture. Social media, news sites, messaging apps and casual browsing are the default destinations. The problem is not merely the student who disappears into their own digital world, research has documented a ‘second-hand distraction’ effect in which one student’s off-task screen use degrades the concentration of those seated nearby, whose peripheral vision catches the movement and brightness of the screen. A single open laptop in a lecture theatre affects not one student but several. The lecturer at the front of the room is competing, without knowing it, with whatever is trending on social media three rows back.
The note-taking research is more nuanced, as this series has noted previously. The finding that handwritten notes produce better conceptual understanding than typed notes is real but context-dependent, and the effect is attenuated when laptop users are trained to take generative rather than transcriptive notes. The practical takeaway for university teaching is not ‘ban laptops universally’ but something more specific: that the design of teaching environments, the explicit instruction given about how to take notes.
One student’s open laptop in a lecture degrades the concentration of every student seated nearby. The screen in your peripheral vision is not your problem. It’s everyone’s.
Critical Hybridity: What Comes After the Backlash
Universities are too large, too diverse and too committed to digital infrastructure to undergo the kind of clean reversal visible in Nordic primary schools. They are not going to remove learning management systems, abandon online submission portals or stop using video conferencing for international collaboration. The digital transformation of higher education is, in most respects, real, useful and irreversible. The question is not whether to be digital, but which parts of university life benefit from being analogue.
What is emerging, hesitantly and imperfectly, might be called critical hybridity: the deliberate combination of digital and analogue practices based on what each is genuinely good for, rather than on what is cheapest, most fashionable or most convenient for administrators. Digital tools are excellent for access to information, for collaboration across distance, for rapid feedback on low-stakes work, for accessibility accommodations. Analogue settings, the supervised exam, the handwritten essay, the seminar discussion, the laboratory session, are excellent for demonstrating individual capability under conditions that cannot be delegated, automated or faked.
And What About the Rest of the World?
The universities of Finland, Sweden, Australia, the UK and their peers in the wealthy world have the institutional capacity, the data, the legal frameworks, the staff development resources, the research culture, to navigate this transition with some sophistication.
Universities in lower-income systems face a different set of pressures. Many are still in the phase of building digital capacity, installing platforms, training staff to use them, extending online learning to students in geographically dispersed or underserved communities. For them, the digital transformation of higher education is still a project in progress, still a marker of institutional modernity, still a goal rather than a problem. The AI cheating crisis, visible and acute in well-resourced universities, is less immediately pressing in systems where AI tool access is still uneven and where examination culture has remained more traditional.
But the AI tools are coming, and they are coming fast, and they are not arriving with an instruction manual explaining how to use them honestly. The universities that are grappling with this are acquiring knowledge that should, in principle, be shared. Whether it will be is the question this series will address in its final instalment: who learns from whom in global education, and who is always left holding the bill for everyone else’s experiments.
SERIES ROADMAP Part I: From Ed-Tech Enthusiasm to De-Digitalisation | Part II: Phones, Pens & Early Literacy | Part III: Attention, Algorithms & Adolescents | Part IV: Universities, AI & the Handwritten Exam (this article) | Part V: A Critical Theory of Educational De-Digitalisation
(The writer, a senior Chartered Accountant and professional banker, is Professor at SLIIT, Malabe. The views and opinions expressed in this article are personal.)
Features
Lest we forget – 2
In 1944 Juan José Arévalo was democratically elected President of Guatemala. At the time a Boston-based banana company in Guatemala, called the United Fruit Company (UFC), had established and was running the country’s harbour, railways and electricity, to facilitate UFC’s fruit export business. It was a ‘state within a state’. The UFC received many concessions, yet corruption was rampant and local workers got a mere pittance as wages ($90 per year). Some 70% of the citizens, mostly of Mayan Indian origin, worked for 3% of the landowners who owned in excess of 550,000 acres. In fact, more than half of government employees were in the payroll of UFC. Needless to say, life under those tyrannical conditions was tough for ordinary Guatemalans who were illiterate and owed their souls to the UFC.
Those were the days of the ‘Cold War’, when a Communist was supposedly seen behind every bush – or a ‘Red under the bed’ – by US Senator Joseph McCarthy and all anti-Communists. A few years later, teachers in Guatemala, and other workers in general, demanded higher wages and were involved in strikes.
In 1951 there was another democratic election, and Jacobo Árbenz was appointed President with a promise to make the lives of Guatemala’s three million citizens better. He implemented a land reform act (No. 900) which forced UFC to sell back undeveloped land to the government, who in turn distributed it to the poor folk for farming sugar, coffee and bananas. It had been UFC’s practice not to develop all the land they owned, keeping some of it on ‘standby’ in case of hurricanes or plant disease. In fact, UFC had utilised only 15% of the land they owned. The new Guatemalan President himself contributed a sizable amount of his own land to the new scheme, while compensation paid to UFC, based on declared land value in the company’s own tax declarations, amounted to US$1.2 million.
However, it was USA’s Secretary of State, John Foster Dulles (after whom Dulles International Airport in Washington, DC is named), not UFC, who sent a letter to the Guatemalan government demanding the enormous sum of US$16 million in reparations. John Dulles and his brother, Allen W. Dulles, then head of the Central Intelligence Agency (CIA), had worked together as partners of the law firm Sullivan & Cromwell – which, not coincidentally, represented UFC. Allen Dulles was also a shareholder and board member of UFC.

Jacobo Árbenz
The Dulles brothers were staunch Calvinists by religious denomination, and to them everything had to be ‘black or white’. At a secret meeting with the UFC board the two brothers were sold a lie saying that President Árbenz was a Communist, which was in turn conveyed to US President Dwight Eisenhower, who allocated money for covert operations to be conducted in Guatemala. Correspondents of The New York Times and Time magazine, sent to Guatemala and paid for by the UFC, began fabricating stories, known today as ‘fake news’, which were duly published by those respected and widely read publications.
One day in Washington, DC, Allen Dulles met Kermit Roosevelt – son of the late US President Theodore Roosevelt – who was in the process of engineering an Iranian regime change, and Dulles offered Roosevelt the opportunity to do something similar in Guatemala. But Roosevelt refused, claiming that there were too many loose ends to contend with. Subsequently, John E. Peurifoy was appointed as US Ambassador to Guatemala to direct operations from within.
The first attempt to undermine the Guatemalan government, code-named ‘Operation PBFORTUNE’, failed due to information leaks. A second attempt, dubbed ‘PBSUCCESS’, was launched later. Using a CIA-established radio station in Miami, Florida, called ‘The Voice of Liberation’ and pretending to be a rebel radio station inside Guatemala, the incumbent President Árbenz was accused of being a Communist. But in reality he was not a Communist, and did not have a single member of the Communist Party in his government. All he had done was to legalise the Communist Party in Guatemala, saying that they were all citizens of the country and democracy demanded it. Yet disinformation was spread liberally by the CIA, by means of fake radio broadcasts and aerial leaflet drops from unmarked American airplanes flown by foreign pilots. The same aircraft were then used to bomb Guatemala.
These American antics were observed by a young Argentinian doctor who happened to be in Guatemala at the time. His name was Ernesto ‘Che’ Guevara, who despite his anti-imperialist revolutionary fervour, chose not to become involved. Later, however, ‘Che’ went to Mexico where he joined the Cuban Castro brothers, Fidel and Raul, in their ultimately successful revolution which culminated in the dethroning of Cuba’s pro-US President Fulgencio Batista, and establishment of a Communist government in the Caribbean’s largest island.
Meanwhile in Guatemala, demoralised by the flood of fake news, in 1954 President Jacobo Árbenz stepped down from office and sought refuge in the Mexican Embassy. He was replaced as President by a US-backed, exiled military man, Carlos Castillo Armas, who was described as “bold but incompetent”.
Carlos Castillo Armas

Carlos Castillo Armas
Guatemalan citizens loyal to the old regime were eliminated according to hit lists prepared by the CIA. Unmarked vans kidnapped people who were tortured and burnt to death. Ultimately, land was given back to the UFC.
It was a rule by terror that lasted for nearly 40 years, during which an estimated 200,000 people died. According to The Guardian, thousands of now declassified documents tell how the US initiated and sustained a murderous war conducted by Guatemalan security forces against civilians suspected of aiding left wing guerrilla movements, with the USA responsible for most of the human rights abuses.
This, I believe, became a template for destabilising and inducing regime change by the USA in other countries.
In the words of former US President Bill Clinton in 1999: “It is important that I state clearly that support for military forces or intelligence units which engaged in violent and widespread repression of the kind described in reports was wrong, and the United States must not repeat that mistake. We must and we will instead continue to support the peace and reconciliation process in Guatemala.”
God Bless America and no one else!
BY GUWAN SEEYA
Features
The Easter investigation must not become ethno-religious politics
Representatives of almost all the main opposition parties were in attendance at the recent book launch by Pivithuru Hela Urumaya leader Udaya Gammanpila. The book written by the PHU leader was his analysis of the Easter bombing of April 2019 that led to the mass killing of 279 persons, caused injuries to more than 500 others and caused panic and shock in the entire country. The Easter bombing was inexplicable for a number of reasons. First, it was perpetrated by suicide bombers who were Sri Lankan Muslims, a community not known for this practice. They targeted Christian churches in particular, which led to the largest number of casualties. The bombing of Sri Lankan Christian churches by Sri Lankan Muslims was also inexplicable in a country that had no history of any serious violence between the two religions.
There were two further inexplicable features of the bombing. The six suicide bombings took place almost simultaneously in different parts of the country. The logistical complexity of this operation exceeded any previously seen in Sri Lanka. Even during the three decade long civil war that pitted the Sri Lankan military against the LTTE, which had earned international notoriety for suicide attacks, Sri Lanka had rarely witnessed such a synchronised operation. The country’s former Attorney General, Dappula de Livera, who investigated the bombing at the time it took place, later stated, upon retirement, that there was a “grand conspiracy” behind the bombings. That phrase has remained central to public debate because it suggested that the visible perpetrators may not have been the only planners behind the attack.
The other inexplicable factor was that intelligence services based in India repeatedly warned their Sri Lankan counterparts that the bombings would take place and even gave specific targets. Later investigations confirmed that warnings were transmitted days before the attacks and repeated again shortly before the explosions, yet they were not acted upon. It was these several inexplicable factors that gave rise to the surmise of a mastermind behind the students and religious fanatics led by the extremist preacher Zahran Hashim from the east of the country, who also blew himself up in the attacks. Even at the time of the bombing there was doubt that such a complex and synchronised operation could have been planned and executed by the motley band who comprised the suicide bombers.
Determined Attempt
The book by PHU leader Gammanpila is a determined attempt to make explicable the inexplicable by marshalling logic and evidence that this complex and synchronised operation was planned and executed by Zahran himself. This is a possible line of argumentation in a democratic society. Competing interpretations of public tragedies are part of political discourse. However, the timing of the intervention makes it politically more significant. The launch of the PHU leader’s book comes at a critical time when the protracted investigation into the Easter bombing appears to be moving forward under the present government.
The performance of the three previous governments at investigating the bombing was desultory at best. The Supreme Court held former President Maithripala Sirisena and several senior officials responsible for failing to act on prior intelligence and ordered compensation to victims. This judicial finding gave legal recognition to what victims had long maintained, that there was a grave dereliction of duty at the highest levels of the state. In recent weeks the investigation has taken a dramatic turn with the arrest and court production of former State Intelligence Service chief Suresh Sallay on allegations linked directly to the attacks. Whether these allegations are ultimately proven or disproven, they indicate that the present phase of the investigation is moving beyond negligence into possible complicity.
This is why the present moment requires political sobriety. There is a danger that the line of political division regarding the investigation into the Easter bombing can take on an ethnic complexion. The insistence that the suicide bombers alone were the planners and executors of the dastardly crime makes the focus invariably one of Muslim extremism, as the suicide bombers were all Muslims. This may unintentionally narrow public attention away from the unanswered questions regarding intelligence failures, possible political manipulation, and the allegations of a broader conspiracy that remain under active investigation. The minority political parties representing ethnic and religious minorities appear to have realised this danger. Their absence from the book launch was politically significant. It suggests an unwillingness to be drawn into a narrative that could once again stigmatise an entire community for the crimes of a handful of extremists and their possible handlers.
Another Tragedy
It would be another tragedy comparable in political consequence to the havoc wreaked by the Easter bombing if moderate mainstream political parties, such as the SJB to which the Leader of the Opposition belongs, were to subscribe to positions merely to score political points against the present government. They need to guard against the promotion of anti-minority sentiment and the fuelling of majority prejudice against ethnic and religious minorities. Indeed, opposition leader Sajith Premadasa in his Easter message said that justice for the victims of the 2019 Sri Lanka Easter Sunday attacks remains a fundamental responsibility of the state and noted that seven years on, both past and present governments have failed to deliver accountability. He added that building a society grounded in trust and peace, uniting all ethnicities, religions and communities, is vital to ensure such tragedies do not occur again.
Sri Lanka’s post war history offers too many examples of how unresolved security crises become vehicles for majoritarian mobilisation. The Easter tragedy itself was followed by waves of anti-Muslim suspicion and violence in some parts of the country. Responsible political leadership should seek to prevent any return to that atmosphere. There are many other legitimate issues on which the moderate and mainstream opposition parties can take the government to task. These include the lack of decisive action against government members accused of corruption, the passing of the entire burden of rising fuel prices on consumers instead of the government sharing the burden, and the failure to hold provincial council elections within the promised timeframe. These are issues that touch the daily lives of citizens and the health of democratic governance. They offer the opposition ample ground on which to build credibility as a government in waiting.
The search for truth and justice over the Easter bombing needs to continue until all those responsible are identified, whether they were direct perpetrators, negligent officials, or political actors who may have exploited the tragedy. This is what the victim families want and the country needs. But this search must not be turned into a partisan and religiously divisive matter such as by claiming that there are more potential suicide bombers lurking in the country who had been followers of Zaharan. If it is, Sri Lanka risks replacing one national tragedy with another. coming together to discredit the ongoing investigations into the Easter bombing of 2019 is an unacceptable use of ethno-religious nationalism to politically challenge the government. The opposition needs to find legitimate issues on which to challenge the government if they are to gain the respect and support of the general public and not their opprobrium.
by Jehan Perera
-
Features4 days agoRanjith Siyambalapitiya turns custodian of a rare living collection
-
News7 days ago2025 GCE AL: 62% qualify for Uni entrance; results of 111 suspended
-
News4 days agoGlobal ‘Walk for Peace’ to be held in Lanka
-
Editorial7 days agoSearch for Easter Sunday terror mastermind
-
News2 days agoLankan-origin actress Subashini found dead in India
-
Opinion6 days agoHidden truth of Sri Lanka’s debt story: The untold narrative behind the report
-
Opinion7 days agoIs there hope for Palestine?
-
Features4 days agoBeyond the Blue Skies: A Tribute to Captain Elmo Jayawardena
